Loss of human β-defensin 1, 2, and 3 expression in oral squamous cell carcinoma

Oral Microbiology and Immunology

Volumn 24, Issue 5, 2009, Pages 353-360

  Joly, S ^a   Compton, L M ^a   Pujol, C ^b   Kurago, Z B ^c   Guthmiller, J M ^d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

defensins; Linkage disequilibrium; Loss of heterozygosity; Oral cancer; Single nucleotide polymorphisms

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CELL DNA; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

5' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE LOSS; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; INTRON; KERATINOCYTE; MOUTH CARCINOMA; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

5' UNTRANSLATED REGIONS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA, NEOPLASM; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENOTYPE; GINGIVA; HAPLOTYPES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTRONS; KERATINOCYTES; LINKAGE DISEQUILIBRIUM; LOSS OF HETEROZYGOSITY; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949197492     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2009.00512.x     Document Type: Article

References (50)

1. Abiko Y, Suraweera AK, Nishimura M et al. Differential expression of human beta-defensin 2 in keratinized and non-keratinized oral epithelial lesions; immunohistochemistry and in situ hybridization. Virchows Arch 2001 : 438 : 248 253.
2. Agapow PM, Burt A. Indices of multilocus linkage disequilibrium. Mol Ecol 2001 : 1 : 101 102.
3. Arimura Y, Ashitani J, Yanagi S et al. Elevated serum beta-defensins concentrations in patients with lung cancer. Anticancer Res 2004 : 24 : 4051 4057.
4. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001 : 357 : 539 545.
5. Beisswenger C, Kandler K, Hess C et al. Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol 2006 : 177 : 1833 1837.
6. Bissell J, Joly S, Johnson GK et al. Expression of β-defensins in gingival health and in periodontal disease. J Oral Pathol Med 2004 : 33 : 278 285.
7. Boniotto M, Ventura M, Eskdale J, Crovella S, Gallagher G. Evidence for duplication of the human defensin gene DEFB4 in chromosomal region 8p22-23 and implications for the analysis of SNP allele distribution. Genet Test 2004 : 8 : 325 327.
8. Braida L, Boniotto M, Pontillo A, Tovo PA, Amoroso A, Crovella S. A single-nucleotide polymorphism in the human β-defensin 1 gene is associated with HIV-1 infection in Italian children. Aids 2004 : 18 : 1598 1600.
9. Brogden KA, Heidari M, Sacco RE et al. Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol 2003 : 18 : 95 99.
10. Dale BA, Krisanaprakornkit S. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 2001 : 30 : 321 327.
11. Donald CD, Sun CQ, Lim SD et al. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 2003 : 83 : 501 505.
12. El-Naggar AK, Coombes MM, Batsakis JG, Hong WK, Goepfert H, Kagan J. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene 1998 : 16 : 2983 2987.
13. Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, Weinberg A. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 2005 : 84 : 445 450.
14. Flanagan JM, Healey S, Young J et al. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8. Genes Chromosomes Cancer 2004 : 40 : 247 260.
15. Frye M, Bargon J, Gropp R. Expression of human beta-defensin-1 promotes differentiation of keratinocytes. J Mol Med 2001 : 79 : 275 282.
16. Gambichler T, Skrygan M, Huyn J et al. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. BMC Cancer 2006 : 6 : 163.
17. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003 : 3 : 710 720.
18. Hamanaka Y, Nakashima M, Wada A et al. Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001 : 49 : 481 487.
19. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004 : 4 : 4688 4694.
20. Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 2003 : 73 : 591 600.
21. Howell MD, Boguniewicz M, Pastore S, Girolomoni G, Leung DY. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 2006 : 121 : 332 338.
22. Hu RC, Xu YJ, Zhang ZX, Ni S, Chen SX. Correlation of HDEFB1 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population. Chin Med J 2004 : 117 : 1637 1641.
23. Ishwad CS, Shuster M, Bockmuhl U et al. Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer 1999 : 80 : 25 31.
24. Joly S, Maze C, McCray PB Jr., Guthmiller JM. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 2004 : 42 : 1024 1029.
25. Joly S, Organ CC, Johnson GK, McCray PB, Guthmiller JM. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Mol Immunol 2005 : 42 : 1073 1084.
26. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human β-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003 : 41 : 90 96.
27. Jurevic RJ, Chrisman P, Mancl L, Livingston R, Dale BA. Single-nucleotide polymorphisms and haplotype analysis in beta-defensin genes in different ethnic populations. Genet Test 2002 : 6 : 261 269.
28. Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol 2002 : 10 : 293 299.
29. Levy H, Raby BA, Lake S et al. Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol 2005 : 115 : 252 258.
30. Liu L, Wang L, Jia HP et al. Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene 1998 : 222 : 237 244.
31. Lu T, Hano H, Meng C, Nagatsuma K, Chiba S, Ikegami M. Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma. World J Gastroenterol 2007 : 13 : 1090 1097.
32. Ma XT, Xu B, An LL et al. Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses. Cancer Res 2006 : 66 : 1169 1176.
33. McCullough M, Jaber M, Barrett AW, Bain L, Speight PM, Porter SR. Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol 2002 : 38 : 391 393.
34. Muscheck M, Sukosd F, Pesti T, Kovacs G. High density deletion mapping of bladder cancer localizes the putative tumor suppressor gene between loci D8S504 and D8S264 at chromosome 8p23.3. Lab Invest 2000 : 80 : 1089 1093.
35. Ono K, Uzawa K, Nakatsuru M et al. Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas. Int J Oncol 2003 : 23 : 297 302.
36. Papo N, Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 2005 : 62 : 784 790.
37. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 1999 : 83 : 318 325.
38. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T. High concentration of beta-defensin 2 in oral squamous cell carcinoma. Anticancer Res 2002 : 22 : 2103 2107.
39. Schuetz AN, Yin-Goen Q, Amin MB et al. Molecular classification of renal tumors by gene expression profiling. J Mol Diagn 2005 : 7 : 206 218.
40. Shnitsar VM, Lisovskiy IL, Soldatkina MA et al. Human beta-defensin 3 (hBD-3) expression in A431 cell line and human vulval tumors. Exp Oncol 2004 : 26 : 328 330.
41. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003 : 170 : 5583 5589.
42. Sudbø J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer 2005 : 115 : 339 345.
43. Sun CQ, Arnold R, Fernandez-Golarz C et al. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006 : 66 : 8542 8549.
44. Sunwoo JB, Sun PC, Gupta VK, Schmidt AP, El-Mofty S, Scholnick SB. Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene 1999 : 18 : 2651 2655.
45. Vankeerberghen A, Nuytten H, Dierickx K, Quirynen M, Cassiman JJ, Cuppens H. Differential induction of human beta-defensin expression by periodontal commensals and pathogens in periodontal pocket epithelial cells. J Periodontol 2005 : 76 : 1293 1303.
46. Vankeerberghen A, Scudiero O, De Boeck K et al. Distribution of human beta-defensin polymorphisms in various control and cystic fibrosis populations. Genomics 2005 : 85 : 574 581.
47. Wehkamp J, Schmid M, Fellermann K, Stange EF. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 2005 : 77 : 460 465.
48. Yang D, Chertov O, Oppenheim JJ. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell Mol Life Sci 2001 : 58 : 978 989.
49. Young AN, de Oliveira Salles PG, Lim SD et al. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 2003 : 27 : 199 205.
50. Zhou X, Jordan RC, Li Y, Huang BL, Wong DT. Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions. Cancer Genet Cytogenet 2005 : 161 : 86 89.